Insider Transactions in Q4 2021 at Cue Biopharma, Inc. (CUE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2021
|
Peter A Kiener |
SELL
Open market or private sale
|
Direct |
1,361
-100.0%
|
$24,498
$18.02 P/Share
|
|
Nov 16
2021
|
Peter A Kiener |
BUY
Exercise of conversion of derivative security
|
Direct |
1,361
+50.0%
|
$2,722
$2.86 P/Share
|
|
Nov 15
2021
|
Anish Suri PRESIDENT AND CSO |
SELL
Open market or private sale
|
Direct |
8,000
-7.84%
|
$144,000
$18.05 P/Share
|
|
Nov 15
2021
|
Anish Suri PRESIDENT AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.27%
|
$64,000
$8.26 P/Share
|
|
Nov 15
2021
|
Peter A Kiener |
SELL
Open market or private sale
|
Direct |
18,815
-100.0%
|
$319,855
$17.92 P/Share
|
|
Nov 15
2021
|
Peter A Kiener |
BUY
Exercise of conversion of derivative security
|
Direct |
18,815
+50.0%
|
$37,630
$2.86 P/Share
|
|
Nov 11
2021
|
Anish Suri PRESIDENT AND CSO |
SELL
Open market or private sale
|
Direct |
20,000
-17.54%
|
$300,000
$15.07 P/Share
|
|
Nov 11
2021
|
Anish Suri PRESIDENT AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.92%
|
$120,000
$6.42 P/Share
|
|
Oct 06
2021
|
Anish Suri PRESIDENT AND CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,134
-13.07%
|
$169,608
$12.97 P/Share
|
|
Oct 03
2021
|
Anish Suri PRESIDENT AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,334
+23.56%
|
-
|
|
Oct 01
2021
|
Kerri Ann Millar CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,251
-10.67%
|
$17,514
$14.21 P/Share
|
|
Oct 01
2021
|
Kerri Ann Millar CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,251
+9.64%
|
$8,757
$7.5 P/Share
|